One-year cost-effectiveness of tiotropium versus ipratopium to treat chronic obstructive pulmonary disease

2004-02-01

The European Respiratory Journal , Volume 23 - Issue 2 p. 241- 249

Additional Metadata
Keywords	Bronchodilator, Chronic obstructive pulmonary disease, Cost-effectiveness, Economic evaluation
Persistent URL	doi.org/10.1183/09031936.03.00083703, hdl.handle.net/1765/64234
Journal	The European Respiratory Journal
Organisation	Erasmus School of Health Policy & Management (ESHPM)
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Oostenbrink, J., Rutten-van Mölken, M., Al, M., van Noord, J., & Vincken, W. (2004). One-year cost-effectiveness of tiotropium versus ipratopium to treat chronic obstructive pulmonary disease. The European Respiratory Journal, 23(2), 241–249. doi:10.1183/09031936.03.00083703

Publication